Study: US experienced the widespread adoption of the ablation prostate surgery robot-assisted in recent years -
A new study reveals that the US experienced widespread adoption of the surgical ablation of the prostate robotic-assisted for treating prostate cancer in recent years. The BJU International study also found that although these surgeries are more expensive than traditional surgeries, their costs decrease over time.
In 01, surgeons began using robotic technologies in the operations to remove the prostate. To examine trends in the use of these robotic-assisted radical prostatectomy (RARP) procedures for patients with prostate cancer, Steven Chang, MD, MS, of Harvard Medical School, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, led a team that analyzed 489.369 men who underwent non-RARP (ie, open or laparoscopic radical prostatectomy) or RARP in the US from 03 to 2010.
over of the study period, the adoption of RARP (defined as the execution of more than 50 percent of the annual radical prostatectomy with robotic approach) rose 0.7 percent to 42 percent of surgeons performing prostatectomies radical. Surgeons who have made at least 25 radical prostatectomies a year were more likely to adopt RARP. In addition, from 05 to 07, adoption was more common among surgeons in teaching hospitals and hospitals in intermediate and large. After 07, the adoption was more common among surgeons in urban hospitals. RARP was more expensive, contributing disproportionately to the increase of 40 percent of annual expenditures of prostate cancer surgery; However, RARP costs generally decreased and reached a plateau at just over $ 10,000 while non-RARP costs rose to nearly $ 9,000 by the end of the study.
"Our findings provide insight on not only the adoption of robotic technology, but the future surgical innovations in terms of the overall trend of the early diffusion, the costs on the potential impact of new and of competitive therapies, and the alternations in best practices such as centralization of care for higher volume suppliers, "said Dr. Chang.
EmoticonEmoticon